Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-09

Clinical Trial Update: Prostate Cancer Screening in Men With Germline BRCA2 Mutations

View source ↗

Summary

Clinical trial update on prostate cancer screening in men with germline BRCA2 mutations; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Prostate Cancer | Status: COMPLETED | Results posted: 2021-02-09